Loading organizations...
Kunling Capital is an investment firm focused on equity investments and capital operations within the digital medical and technology sectors. The company identifies and cultivates high-potential opportunities, providing strategic guidance and value-added services. Leveraging deep industry insights and an extensive network, it builds an influential investment platform.
The firm’s core team brings nearly two decades of equity investment and capital operation experience. Members previously served at leading domestic and international institutions, including Haitong Kaiyuan and UBS Securities. This pedigree ensures a deep understanding of China's A-share and global capital markets, informing a rigorous investment approach.
Kunling Capital attracts diverse limited partners, including government guidance funds, market-oriented fund of funds, and strategic industrial groups. Its vision is to catalyze growth within the digital medical and technology industries by fostering a collaborative ecosystem. The firm accelerates portfolio company development through strategic resource coordination and strong industry partnerships.
Kunling Capital has 3 tracked investments across 3 companies. The latest tracked deal is $231.5M Series F in Beijing Yuan Xin in August 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 12, 2021 | Beijing Yuan Xin | $231.5M Series F | — | AB Initio Capital, B Capital Group, CITIC Securities, Future Innovation, HEL VED, Stella Zhou, Index Capital, OrbiMed, Sequoia Capital, Springhill, UOB |
| Aug 3, 2021 | Yuanxin Huibao | $232.1M Series F | — | B Capital Group, CITIC Securities, HEL VED, Hongshan Capital Group (Sequoia Capital China), INCE Capital, OrbiMed, Springhill, UOB |
| Apr 2, 2020 | Job Cloud Education Technology Group | $14.1M Series B | Kunling Capital | — |